External action of di- and polyamines on maxi calcium-activated potassium channels: an electrophysiological and molecular modeling study.
In this study we compared polyamines to various diamines, and we modeled flexibility as well as hydrophobicity properties of these molecules to examine possible structural differences that could explain their external effects on the channels. The natural polyamines (putrescine, cadaverine, spermidine, spermine) and diamines increasing in CH2 chain length from C2 to C12 were used to probe maxi calcium-activated potassium (BK) channels in GH3 pituitary tumor cells when applied extracellularly. In single-channel recordings we found polyamines as well as diamines up to 1,10-diaminodecane to be ineffective in altering channel current amplitudes or kinetics. In contrast, 1,12-diamino dodecane (1,12-DD) was found to be a reversible blocker, with a blocking site at an electrical distance (z delta) of 0.72 within the channel. It reduced single-channel current amplitude, mean channel open time, and channel open probability. In computer simulations structural data, such as flexibility, hydration, and log D values, were calculated. 1,12-DD showed the largest flexibility of all diamines (minimum N-N distance 9.9 A) combined with a marked hydrophobicity due to a 4-5 A hydrophobic intersegment between hydrophilic ends in the molecule, as confirmed by GRID water probe maps and a log D value of -1.82 at pH 7.2. We propose that the amount of hydration of the molecule, more than its flexibility, constitutes an essential parameter for its ability to act as a channel blocker.
Weiger
T M
TM
Department of Animal Physiology, Institute of Zoology, University of Salzburg, Austria. thomas.weiger@sbg.ac.at
Langer
T
T
Hermann
A
A
D000818:Animals; D002103:Cadaverine / Q000494:pharmacology; D002462:Cell Membrane / Q000502:physiology; D003959:Diamines / Q000737:chemistry / Q000494:pharmacology*; D007700:Kinetics; D051036:Large-Conductance Calcium-Activated Potassium Channels; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D008958:Models, Molecular; D008968:Molecular Conformation; D010911:Pituitary Neoplasms; D011073:Polyamines / Q000494:pharmacology*; D015221:Potassium Channels / Q000737:chemistry* / Q000502:physiology*; D024681:Potassium Channels, Calcium-Activated; D011487:Protein Conformation; D011700:Putrescine / Q000494:pharmacology; D013095:Spermidine / Q000494:pharmacology; D013096:Spermine / Q000494:pharmacology; D013329:Structure-Activity Relationship; D019789:Tetraethylammonium / Q000737:chemistry / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D003959:Diamines; D051036:Large-Conductance Calcium-Activated Potassium Channels; D011073:Polyamines; D015221:Potassium Channels; D024681:Potassium Channels, Calcium-Activated; C016417:1,12-dodecamethylenediamine; D013096:Spermine; D019789:Tetraethylammonium; D002103:Cadaverine; D013095:Spermidine; D011700:Putrescine